Allogeneic invariant natural killer T cells (allo-iNKTs) from a healthy donor have been shown to have therapeutic effects in treatment-resistant cancers and improve survival from COVID-19-related acute respiratory failure ...
Oct 20, 2023
0
24
A new study led by Luísa Figueiredo, group leader at the Instituto de Medicina Molecular João Lobo Antunes (iMM; Portugal), and published in Nature Microbiology found a new strategy by the host to cope with Trypanosoma ...
Oct 12, 2023
0
37
Emory Vaccine Center researchers say they have identified the Achilles heel of SARS-CoV-2, the virus that causes COVID-19.
Sep 26, 2023
0
82
How microbiota—microbes that live on human surfaces—impact cancer development and therapy has become an expansive area of research.
Sep 18, 2023
0
9
Scientists studying how poxviruses evade natural defenses in human cells have identified a new approach to treatment that may be more durable than current treatments.
Aug 9, 2023
0
26
Scientists have relied on animal models as an alternative to testing on human tissues and cells for decades. But not just any organism can adequately model how human cells behave. Researchers take into account how quickly ...
Aug 8, 2023
0
1
Herpes viruses are treacherous: once you are infected, you can never get rid of the virus. This is because herpes viruses lie dormant in certain host cells in the body for a lifetime. Almost every adult unknowingly carries ...
Aug 7, 2023
0
36
In a major Swedish study, researchers have discovered a link between the levels of certain bacteria living in the gut and coronary atherosclerotic plaques. Such atherosclerotic plaques, which are formed by the build-up of ...
Jul 13, 2023
0
0
A group of scientists at UNSW Sydney have discovered that a type of bacteria known as Aeromonas are the second most prevalent bacterial pathogen found in patients with gastroenteritis.
Jun 29, 2023
0
6
Clinicians have a new standard for graft-versus-host disease (GVHD) prevention after allogeneic hematopoietic stem cell transplantation, according to results from a phase III study published June 22 in the New England Journal ...
Jun 22, 2023
0
37
